Assessing the cardiac safety of ebastine: proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997
Gespeichert in:
| Körperschaft: | |
|---|---|
| Weitere Verfasser: | |
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Auckland [u.a.]
Adis International Limited
1999
|
| Schriftenreihe: | Drug safety
vol. 21, supplement 1 |
| Schlagworte: | |
| Beschreibung: | 92 Seiten Diagramme |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV013508504 | ||
| 003 | DE-604 | ||
| 005 | 20180105 | ||
| 007 | t | ||
| 008 | 010102s1999 |||| |||| 10||| eng d | ||
| 035 | |a (OCoLC)67741859 | ||
| 035 | |a (DE-599)BVBBV013508504 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 | ||
| 111 | 2 | |a Round Table Conference Entitled The Value of Preclinical Models in the Prediction of Antihistamine Induced Torsade de Pointes in Man |d 1997 |c Barcelona |j Verfasser |0 (DE-588)1243794-3 |4 aut | |
| 245 | 1 | 0 | |a Assessing the cardiac safety of ebastine |b proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 |c guest editor Arthur J. Moss |
| 264 | 1 | |a Auckland [u.a.] |b Adis International Limited |c 1999 | |
| 300 | |a 92 Seiten |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drug safety |v vol. 21, supplement 1 | |
| 650 | 0 | 7 | |a Kardiotoxizität |0 (DE-588)4163323-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Herzkrankheit |0 (DE-588)4024663-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Ebastin |0 (DE-588)4369490-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1997 |z Barcelona |2 gnd-content | |
| 689 | 0 | 0 | |a Ebastin |0 (DE-588)4369490-1 |D s |
| 689 | 0 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 0 | 2 | |a Herzkrankheit |0 (DE-588)4024663-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Ebastin |0 (DE-588)4369490-1 |D s |
| 689 | 1 | 1 | |a Kardiotoxizität |0 (DE-588)4163323-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Moss, Arthur J. |4 edt | |
| 830 | 0 | |a Drug safety |v vol. 21, supplement 1 |w (DE-604)BV002725050 |9 21, Suppl. 1 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009221866 | ||
Datensatz im Suchindex
| _version_ | 1804128301624590336 |
|---|---|
| any_adam_object | |
| author2 | Moss, Arthur J. |
| author2_role | edt |
| author2_variant | a j m aj ajm |
| author_corporate | Round Table Conference Entitled The Value of Preclinical Models in the Prediction of Antihistamine Induced Torsade de Pointes in Man Barcelona |
| author_corporate_role | aut |
| author_facet | Moss, Arthur J. Round Table Conference Entitled The Value of Preclinical Models in the Prediction of Antihistamine Induced Torsade de Pointes in Man Barcelona |
| author_sort | Round Table Conference Entitled The Value of Preclinical Models in the Prediction of Antihistamine Induced Torsade de Pointes in Man Barcelona |
| building | Verbundindex |
| bvnumber | BV013508504 |
| ctrlnum | (OCoLC)67741859 (DE-599)BVBBV013508504 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01871nam a2200421 cb4500</leader><controlfield tag="001">BV013508504</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180105 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">010102s1999 |||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)67741859</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013508504</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Round Table Conference Entitled The Value of Preclinical Models in the Prediction of Antihistamine Induced Torsade de Pointes in Man</subfield><subfield code="d">1997</subfield><subfield code="c">Barcelona</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)1243794-3</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing the cardiac safety of ebastine</subfield><subfield code="b">proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997</subfield><subfield code="c">guest editor Arthur J. Moss</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland [u.a.]</subfield><subfield code="b">Adis International Limited</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">92 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drug safety</subfield><subfield code="v">vol. 21, supplement 1</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kardiotoxizität</subfield><subfield code="0">(DE-588)4163323-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ebastin</subfield><subfield code="0">(DE-588)4369490-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1997</subfield><subfield code="z">Barcelona</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Ebastin</subfield><subfield code="0">(DE-588)4369490-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Ebastin</subfield><subfield code="0">(DE-588)4369490-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Kardiotoxizität</subfield><subfield code="0">(DE-588)4163323-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moss, Arthur J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drug safety</subfield><subfield code="v">vol. 21, supplement 1</subfield><subfield code="w">(DE-604)BV002725050</subfield><subfield code="9">21, Suppl. 1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009221866</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1997 Barcelona gnd-content |
| genre_facet | Konferenzschrift 1997 Barcelona |
| id | DE-604.BV013508504 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:47:04Z |
| institution | BVB |
| institution_GND | (DE-588)1243794-3 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009221866 |
| oclc_num | 67741859 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | 92 Seiten Diagramme |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Adis International Limited |
| record_format | marc |
| series | Drug safety |
| series2 | Drug safety |
| spelling | Round Table Conference Entitled The Value of Preclinical Models in the Prediction of Antihistamine Induced Torsade de Pointes in Man 1997 Barcelona Verfasser (DE-588)1243794-3 aut Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 guest editor Arthur J. Moss Auckland [u.a.] Adis International Limited 1999 92 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier Drug safety vol. 21, supplement 1 Kardiotoxizität (DE-588)4163323-4 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Herzkrankheit (DE-588)4024663-2 gnd rswk-swf Ebastin (DE-588)4369490-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1997 Barcelona gnd-content Ebastin (DE-588)4369490-1 s Arzneimittelnebenwirkung (DE-588)4003134-2 s Herzkrankheit (DE-588)4024663-2 s DE-604 Kardiotoxizität (DE-588)4163323-4 s Moss, Arthur J. edt Drug safety vol. 21, supplement 1 (DE-604)BV002725050 21, Suppl. 1 |
| spellingShingle | Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 Drug safety Kardiotoxizität (DE-588)4163323-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Herzkrankheit (DE-588)4024663-2 gnd Ebastin (DE-588)4369490-1 gnd |
| subject_GND | (DE-588)4163323-4 (DE-588)4003134-2 (DE-588)4024663-2 (DE-588)4369490-1 (DE-588)1071861417 |
| title | Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 |
| title_auth | Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 |
| title_exact_search | Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 |
| title_full | Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 guest editor Arthur J. Moss |
| title_fullStr | Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 guest editor Arthur J. Moss |
| title_full_unstemmed | Assessing the cardiac safety of ebastine proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 guest editor Arthur J. Moss |
| title_short | Assessing the cardiac safety of ebastine |
| title_sort | assessing the cardiac safety of ebastine proceedings of the round table conference entitled the value of preclinical models in the prediction of antihistamine induced torsade de pointes in man held in barcelona april 25 1997 |
| title_sub | proceedings of the Round-Table Conference Entitled "The Value of Preclinical Models in the Prediction of Antihistamine-Induced Torsade de Pointes in Man", held in Barcelona, April 25, 1997 |
| topic | Kardiotoxizität (DE-588)4163323-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Herzkrankheit (DE-588)4024663-2 gnd Ebastin (DE-588)4369490-1 gnd |
| topic_facet | Kardiotoxizität Arzneimittelnebenwirkung Herzkrankheit Ebastin Konferenzschrift 1997 Barcelona |
| volume_link | (DE-604)BV002725050 |
| work_keys_str_mv | AT roundtableconferenceentitledthevalueofpreclinicalmodelsinthepredictionofantihistamineinducedtorsadedepointesinmanbarcelona assessingthecardiacsafetyofebastineproceedingsoftheroundtableconferenceentitledthevalueofpreclinicalmodelsinthepredictionofantihistamineinducedtorsadedepointesinmanheldinbarcelonaapril251997 AT mossarthurj assessingthecardiacsafetyofebastineproceedingsoftheroundtableconferenceentitledthevalueofpreclinicalmodelsinthepredictionofantihistamineinducedtorsadedepointesinmanheldinbarcelonaapril251997 |